Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index.

Cumulative burden of psychiatric disorders and self-harm across 26 adult cancers

Open access
Chang, Wai Hoong, Lai, Alvina G. · 2022 · Nature Medicine

Published version of a preprint

Abstract

Cancer is a life-altering event causing considerable psychological distress. However, information on the total burden of psychiatric disorders across all common adult cancers and therapy exposures has remained scarce. Here, we estimated the risk of self-harm after incident psychiatric disorder diagnosis in patients with cancer and the risk of unnatural deaths after self-harm in 459,542 individuals. Depression was the most common psychiatric disorder in patients with cancer. Patients who received chemotherapy, radiotherapy and surgery had the highest cumulative burden of psychiatric disorders. Patients treated with alkylating agent chemotherapeutics had the highest burden of psychiatric disorders, whereas those treated with kinase inhibitors had the lowest burden. All mental illnesses were associated with an increased risk of subsequent self-harm, where the highest risk was observed within 12 months of the mental illness diagnosis. Patients who harmed themselves were 6.8 times more likely to die of unnatural causes of death compared with controls within 12 months of self-harm (hazard ratio (HR), 6.8; 95% confidence interval (CI), 4.3–10.7). The risk of unnatural death after 12 months was markedly lower (HR, 2.0; 95% CI, 1.5–2.7). We provide an extensive knowledge base to help inform collaborative cancer-psychiatric care initiatives by prioritizing patients who are most at risk.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41591-022-01740-3

Cites

62 of 63 references verified1 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Cumulative burden of psychiatric disorders in patients with cancer. a–c, Distribution of cumulative burden by 26 cancer diagnostic groups (a), 10 cancer treatment modalities (b) and 11 chemotherapy drug classes (c). All data and 95% CIs are provided in the supplementary tables.
Fig. 1 Cumulative burden of psychiatric disorders in patients with cancer. a–c, Distribution of cumulative burden by 26 cancer diagnostic groups (a), 10 cancer treatment modalities (b) and 11 chemotherapy drug classes (c). All data and 95% CIs are provided in the supplementary tables.CC BY · PubMed Central
Fig. 2 Temporal variation in the first diagnosis of psychiatric disorder in relation to the time of the first occurrence of self-harm. a, By cancer type. b, By age group. c, By index of multiple deprivation (IMD) status. d, By the number of prevalent noncancer comorbidities. Bars on the left side of the graphs indicate the proportion of individuals who were diagnosed with a psychiatric disorder before the first self-harm event. Bars on the right side of the graphs indicate the proportion of individuals who were diagnosed with a psychiatric disorder after the first self-harm event. Prevalence ratios (prevalence of psychiatric disorder diagnosis before self-harm divided by prevalence of psychiatric disorder after self-harm) are shown, alongside 95% CIs.
Fig. 2 Temporal variation in the first diagnosis of psychiatric disorder in relation to the time of the first occurrence of self-harm. a, By cancer type. b, By age group. c, By index of multiple deprivation (IMD) status. d, By the number of prevalent noncancer comorbidities. Bars on the left side of the graphs indicate the proportion of individuals who were diagnosed with a psychiatric disorder before the first self-harm event. Bars on the right side of the graphs indicate the proportion of individuals who were diagnosed with a psychiatric disorder after the first self-harm event. Prevalence ratios (prevalence of psychiatric disorder diagnosis before self-harm divided by prevalence of psychiatric disorder after self-harm) are shown, alongside 95% CIs.CC BY · PubMed Central
Fig. 3 Total burden and risk of self-harm after diagnosis of psychiatric disorders in patients with cancer. Case (with psychiatric disorder) and control (no psychiatric disorder) groups were obtained via propensity score matching (Extended Data Fig. 1). Controls were matched by age at cancer diagnosis, cancer type, sex, IMD and primary care practice ID. a, Cumulative burden of all self-harm events in cases and controls. b, Cumulative incidence of the first self-harm event in cases and controls. Gray’s test was used to assess statistical significance. c, HRs for risk of self-harm for each psychiatric disorder were further adjusted for noncancer comorbidities, cancer treatment and presence of other psychiatric disorders. The numbers of patients with psychiatric disorder were as follows: depression, 21,609; anxiety disorder, 20,070; schizophrenia, 7,679; bipolar disorder, 557; personality disorder, 194; substance abuse, 115,868. The numbers of matched controls for each psychiatric disorder were as follows: depression, 75,087; anxiety disorder, 67,887; schizophrenia, 23,130; bipolar disorder, 1,636; personality disorder, 628; and substance abuse, 126,057. Self-harm risks during the first 12 months and subsequent years of follow-up are shown. Strata with low event numbers (n < 10) were not analyzed. Data are presented as HRs, and error bars represent 95% CIs. Numbers in the graphs in panel c represent P values. The likelihood ratio test was used. Full data and 95% CIs are provided in the supplementary tables.
Fig. 3 Total burden and risk of self-harm after diagnosis of psychiatric disorders in patients with cancer. Case (with psychiatric disorder) and control (no psychiatric disorder) groups were obtained via propensity score matching (Extended Data Fig. 1). Controls were matched by age at cancer diagnosis, cancer type, sex, IMD and primary care practice ID. a, Cumulative burden of all self-harm events in cases and controls. b, Cumulative incidence of the first self-harm event in cases and controls. Gray’s test was used to assess statistical significance. c, HRs for risk of self-harm for each psychiatric disorder were further adjusted for noncancer comorbidities, cancer treatment and presence of other psychiatric disorders. The numbers of patients with psychiatric disorder were as follows: depression, 21,609; anxiety disorder, 20,070; schizophrenia, 7,679; bipolar disorder, 557; personality disorder, 194; substance abuse, 115,868. The numbers of matched controls for each psychiatric disorder were as follows: depression, 75,087; anxiety disorder, 67,887; schizophrenia, 23,130; bipolar disorder, 1,636; personality disorder, 628; and substance abuse, 126,057. Self-harm risks during the first 12 months and subsequent years of follow-up are shown. Strata with low event numbers (n < 10) were not analyzed. Data are presented as HRs, and error bars represent 95% CIs. Numbers in the graphs in panel c represent P values. The likelihood ratio test was used. Full data and 95% CIs are provided in the supplementary tables.CC BY · PubMed Central
Fig. 4 Cumulative incidence of all-cause mortality and YLL after diagnosis of psychiatric disorders in patients with cancer. Case (with psychiatric disorder) and control (no psychiatric disorder) groups were obtained via propensity score matching (Extended Data Fig. 1). Controls were matched by age at cancer diagnosis, cancer type, sex, IMD and primary care practice ID. a, Cumulative incidence curves for all-cause mortality after psychiatric disorder diagnosis in matched case and control groups. The log-rank test was used. b, Excess YLL attributable to psychiatric disorders in patients with cancer. Radar plots depict the difference in YLL between matched cases and controls. Excess YLL was estimated based on the age of onset of a psychiatric disorder. All data and 95% CIs are provided in Supplementary Table S7.
Fig. 4 Cumulative incidence of all-cause mortality and YLL after diagnosis of psychiatric disorders in patients with cancer. Case (with psychiatric disorder) and control (no psychiatric disorder) groups were obtained via propensity score matching (Extended Data Fig. 1). Controls were matched by age at cancer diagnosis, cancer type, sex, IMD and primary care practice ID. a, Cumulative incidence curves for all-cause mortality after psychiatric disorder diagnosis in matched case and control groups. The log-rank test was used. b, Excess YLL attributable to psychiatric disorders in patients with cancer. Radar plots depict the difference in YLL between matched cases and controls. Excess YLL was estimated based on the age of onset of a psychiatric disorder. All data and 95% CIs are provided in Supplementary Table S7.CC BY · PubMed Central
Fig. 5 Risk of suicide and other causes of death following self-harm in patients with cancer. Case (self-harm) and control (no self-harm) groups were obtained via propensity score matching (Extended Data Fig. 2). Controls were matched by age at cancer diagnosis, cancer type, sex, IMD and primary care practice ID. a, HRs for risk of suicide and other causes of death were further adjusted for noncancer comorbidities, cancer treatment and presence of psychiatric disorders. Mortality risks during the first 12 months and subsequent years of follow-up are shown. We identified 5,683 individuals with incident self-harm and 18,407 matched controls. Data are presented as HRs, and error bars represent 95% CIs. The likelihood ratio test was used. Numbers in the graphs represent P values. b, Cumulative incidence curves of death due to all causes, natural causes and unnatural causes after self-harm in matched case and control groups. Gray’s test was used. *The results for natural deaths are adjusted for competing risk of unnatural deaths. The results for unnatural deaths are adjusted for competing risk of natural deaths.
Fig. 5 Risk of suicide and other causes of death following self-harm in patients with cancer. Case (self-harm) and control (no self-harm) groups were obtained via propensity score matching (Extended Data Fig. 2). Controls were matched by age at cancer diagnosis, cancer type, sex, IMD and primary care practice ID. a, HRs for risk of suicide and other causes of death were further adjusted for noncancer comorbidities, cancer treatment and presence of psychiatric disorders. Mortality risks during the first 12 months and subsequent years of follow-up are shown. We identified 5,683 individuals with incident self-harm and 18,407 matched controls. Data are presented as HRs, and error bars represent 95% CIs. The likelihood ratio test was used. Numbers in the graphs represent P values. b, Cumulative incidence curves of death due to all causes, natural causes and unnatural causes after self-harm in matched case and control groups. Gray’s test was used. *The results for natural deaths are adjusted for competing risk of unnatural deaths. The results for unnatural deaths are adjusted for competing risk of natural deaths.CC BY · PubMed Central
Extended Data Fig. 1 Flow diagram of case and control identification via propensity score matching for analyses on risk of self-harm after the diagnosis of psychiatric disorders in patients with cancer. Psychiatric disorders diagnostic groups are as follow: (a) depression, (b) anxiety disorders, (c) schizophrenia, schizotypal and delusional disorders, (d) bipolar affective disorder and mania (e) personality disorders and (f) substance abuse. Patients can be included in more than one diagnostic group for cases. Controls were matched by age at cancer diagnosis, cancer type, sex, Index of Multiple Deprivation and primary care practice ID.
Extended Data Fig. 1 Flow diagram of case and control identification via propensity score matching for analyses on risk of self-harm after the diagnosis of psychiatric disorders in patients with cancer. Psychiatric disorders diagnostic groups are as follow: (a) depression, (b) anxiety disorders, (c) schizophrenia, schizotypal and delusional disorders, (d) bipolar affective disorder and mania (e) personality disorders and (f) substance abuse. Patients can be included in more than one diagnostic group for cases. Controls were matched by age at cancer diagnosis, cancer type, sex, Index of Multiple Deprivation and primary care practice ID.CC BY · PubMed Central
Extended Data Fig. 2 Flow diagram of case and control identification via propensity score matching for analysis on the risk of suicide and other causes of death following self-harm in patients with cancer. Controls were matched by age at cancer diagnosis, cancer type, sex, Index of Multiple Deprivation and primary care practice ID.
Extended Data Fig. 2 Flow diagram of case and control identification via propensity score matching for analysis on the risk of suicide and other causes of death following self-harm in patients with cancer. Controls were matched by age at cancer diagnosis, cancer type, sex, Index of Multiple Deprivation and primary care practice ID.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 61 references

Cited by

See all 81

Metadata

Authors
Chang, W. H., & Lai, A. G.
Affiliations
University College London (GB)
Corresponding author
Lai, Alvina G.
Venue
Nature Medicine
Published
2022-03-28
Volume
28
Issue
4
Pages
860-870
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W4221093065
Cited by
81
References
61
Citations by year
2026: 10 · 2025: 19 · 2024: 21 · 2023: 25 · 2022: 6
FWCI
7.43
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Medicine (publishedVersion, cc-by)
  • medRxiv (acceptedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Funders
Wellcome Trust (204841/Z/16/Z)
Topics
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
Keywords
mental illness, self-harm, cancer, depression, cumulative burden, unnatural death, chemotherapy, alkylating agents, kinase inhibitors, radiotherapy, cancer surgery
MeSH terms
Adult, Mental Disorders, Humans, Neoplasms, Risk Factors, Suicide, Proportional Hazards Models, Self-Injurious Behavior

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cumulative burden of psychiatric disorders and self-harm across 26 adult cancers. https://app.cochat.ai/papers/10.1038/s41591-022-01740-3
The paper
Chang, W. H., & Lai, A. G. (2022). Cumulative burden of psychiatric disorders and self-harm across 26 adult cancers. Nature Medicine. https://doi.org/10.1038/s41591-022-01740-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.